An LC-MS-MS method for quantitative analysis of six trimethoxyamphetamine designer drugs in rat plasma, and its application to a pharmacokinetic study

Forensic Toxicology

Volumn 31, Issue 2, 2013, Pages 197-203

  Pirisi, Maria Antonietta ^a   Nieddu, Maria ^a   Burrai, Lucia ^a   Carta, Antonio ^a   Briguglio, Irene ^a   Baralla, Elena ^a   Demontis, Maria Piera ^a   Varoni, Maria Vittoria ^a   Boatto, Gianpiero ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Designer drug; LC MS MS; Pharmacokinetic study; Rat plasma; Solid phase extraction (SPE); Trimethoxyamphetamines (TMAs)

Indexed keywords

2,3,4 TRIMETHOXYAMPHETAMINE; 2,3,5 TRIMETHOXYAMPHETAMINE; 2,3,6 TRIMETHOXYAMPHETAMINE; 2,4,5 TRIMETHOXYAMPHETAMINE; 2,4,6 TRIMETHOXYAMPHETAMINE; 3,4,5 TRIMETHOXYAMPHETAMINE; ACETONITRILE; AMPHETAMINE; DESIGNER DRUG; FORMIC ACID; MESCALINE; TRIMETHOXYAMPHETAMINE; UNCLASSIFIED DRUG; WATER;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CALIBRATION; DRUG IDENTIFICATION; ELECTROSPRAY; ISOMER; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

RATTUS;

EID: 84879793100     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-012-0177-y     Document Type: Article

References (22)

1. Ewald AH, Fritschi G, Maurer HH (2006) Designer drug 2,4,5- trimethoxyamphetamine (TMA-2): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. J Mass Spectrom 41:1140-1148
2. Tsujikawa K, Kanamori T, Kuwayama K, Miyaguchi H, Iwata Y, Inoue H (2006) Analytical profiles for 3,4,5-, 2,4,5-, and 2,4,6-trimethoxyamphetamine. Microgram 4:12-14
3. Namera A, Nakamoto A, Saito T, Nagao M (2011) Colorimetric and chromatographic analysis of designer drugs in biological materials: a comprehensive review. Forensic Toxicol 29:1-24
4. Zaitsu K, Katagi M, Tatsuno M, Sato T, Tsuchihashi H, Suzuki K (2011) Recently abused β-keto derivatives of 3,4-methylenedioxyphenylalkylamines: a review of their metabolism and toxicological analysis. Forensic Toxicol 29:73-84
5. Shulgin A (1991) Pihkal, a chemical love story. Transform Press, Berkeley
6. EMCDDA (European Monitoring Centre for Drugs and Drug Addiction) (2004) Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs. EMCDDA, Lisbon
7. Council of the European Union (2003) Council decision 2003/847/JHA of 27 November 2003 concerning control measures and criminal sanctions in respect of the new synthetic drugs 2C-I, 2C-T-2, 2C-T-7 and TMA-2. Off J Eur Union L 321:64-65
8. Nieddu M, Boatto G, Pirisi MA, Azara E, Marchetti M (2008) LC-MS analysis of trimethoxyamphetamine designer drugs (TMA series) from urine samples. J Chromatogr B 867:126-130
9. Zaitsu Z, Katagi M, Kamata H, Kamata T, Shima N, Miki A, Iwamura T, Tsuchilashi H (2008) Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography-mass spectrometry (GC-MS). J Mass Spectrom 43:528-534
10. Boatto G, Nieddu M, Carta A, Pau A, Asproni B, Cerri R (2005) Determination of amphetamine-derived designer drugs in human urine by SPE extraction and capillary electrophoresis with mass spectrometry detection. J Chromatogr B 814:93-98
11. Nieddu M, Boatto G, Dessì G (2007) Determination of 4-Alkyl 2,5-dimethoxyamphetamine derivatives by capillary electrophoresis with mass spectrometry detection from urine samples. J Chromatogr B 852:578-581
12. Nieddu M, Boatto G, Sini L, Dessì G (2007) Determination of paramethoxyamphetamine by capillary electrophoresis with diode array detection from urine and plasma samples. J Liq Chromatogr Relat Technol 30:431-438
13. Boatto G, Nieddu M, Pirisi MA, Dessì G (2007) Simultaneous determination of new thioamphetamine designer drugs in plasma by capillary electrophoresis coupled with mass spectrometry. Rapid Commun Mass Spectrom 21:3716-3720
14. Nieddu M, Boatto G, Pirisi MA, Baralla E (2009) Multi-residue analysis of eight thioamphetamine designer drugs in human urine by LC-MS/MS. Rapid Commun Mass Spectrom 23:3051-3056
15. Nieddu M, Boatto G, Pirisi MA, Dessì G (2010) A rapid method for determination of four thioamphetamine designer drugs (ALEPH-4, ALEPH-8, ALEPH-13, ALEPH-17) in human urine. J Liq Chromatogr Relat Techonol 33:1351-1358
16. Nieddu M, Boatto G, Pirisi MA, Dessì G (2010) Determination of four thiophenethylamine designer drugs (2C-T-4, 2C-T-8, 2C-T-13, 2C-T-17) in human urine by capillary electrophoresis-mass spectrometry. Rapid Commun Mass Spectrom 24:2357-2362
17. Peters FT, Maureer HH (2002) Bioanalytical method validation and its implications for forensic and clinical toxicology. Accred Qual Assur 7:441-444
18. Taverniers I, de Loose M, Van Bockstaele E (2004) Analytical method validation and quality assurance. Trends Anal Chem 23:533-536
19. Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216-224
20. Souverain S, Rudaz S, Veuthey JL (2004) Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures. J Chromatogr A 1058:61-66
21. Annesley T (2003) Ion suppression in mass spectrometry. Clin Chem 49:1041-1044
22. Maurer HH (2007) Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 388:1315-1325